# Arcus Biosciences, Inc.: Form 8-K, filed Feb 1, 2021

- Company: [Arcus Biosciences, Inc.](/companies/rcus.md) (CIK 1724521)
- Form: 8-K
- Filed: 2021-02-01
- Accepted by EDGAR: Feb 1, 2021, 08:08 ET
- Period: 2021-01-31
- Accession: 0001564590-21-003492
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1724521/000156459021003492/rcus-8k_20210131.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1724521/000156459021003492/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1724521/000156459021003492/rcus-8k_20210131.htm

Filed Feb 1, 2021.
Source: SEC EDGAR, the filing index for accession 0001564590-21-003492. Last ingested by Listed: Nov 4, 2026, 17:06 ET. No prices; not investment advice.
